Method and device comprising an optical fiber located inside a channel for determining the concentration of analyte in whole blood based on change of reflected light wavelength

US11480558B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11480558-B2
Application numberUS-201816621009-A
CountryUS
Kind codeB2
Filing dateJun 7, 2018
Priority dateJun 15, 2017
Publication dateOct 25, 2022
Grant dateOct 25, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A method and a device for determining the concentration of an analyte in whole blood is disclosed. In one embodiment, the method includes generating a plasma layer in the whole blood sample. Furthermore, the method includes exposing the plasma layer to light. The method also includes capturing light reflected from the plasma layer. Additionally, the method includes analyzing the reflected light to determine the concentration of the analyte.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of determining the concentration of an analyte in a whole blood sample, the method comprising: flowing a whole blood sample through a channel; generating a plasma layer in the channel, the plasma layer being devoid of blood cells; directing light at the plasma layer; passing the light through an optical fiber located inside the channel and extending in parallel with the channel to reflect the light off of the plasma layer multiple times; capturing light reflected off of the plasma layer; and analyzing the reflected light to determine the concentration of the analyte. 2. The method of claim 1 , wherein when the whole blood sample flows through the channel the blood cells migrate to the center of the channel thereby creating a plasma layer at the inner surface of the channel. 3. The method of claim 1 , wherein in generating a plasma layer in the whole blood sample, the method comprises using the optical fiber inside the channel, wherein the whole blood surrounds the optical fiber as it flows through the channel. 4. The method of claim 1 , wherein the light is directed at the plasma layer at an angle sufficient to cause a reflection off of the plasma layer. 5. The method of claim 4 , further comprising redirecting the reflected light back to the plasma layer. 6. The method of claim 1 , wherein the light is directed at the inner surface of the optical fiber. 7. The method of claim 1 , wherein in analyzing the reflected light to determine the concentration of the analyte, the method comprises: detecting a change in the wavelength of the reflected light; and determining the concentration of the analyte in the whole blood sample based on the wavelength of the reflected light. 8. The method of claim 1 , wherein the reflected light is captured using a spectrophotometer. 9. The method of claim 1 , wherein the analyte is hemoglobin. 10. A device for determining the concentration of an analyte in a whole blood sample, the device comprising: a channel configured to carry whole blood; a light source configured to direct light on the channel; an optical fiber through which the light passes and is reflected multiple times to form reflected light, the optical fiber being located inside the channel and extending in parallel with the channel; and a measuring unit configured to: capture the reflected light exiting from the channel; and compute a change in wavelength of the reflected light, wherein the change in the wavelength of the reflected light is proportional to the concentration of the analyte in the whole blood. 11. The device of claim 10 , wherein when the whole blood is flown through the channel, the blood cells migrate to the center of the channel thereby creating a plasma layer at the inner surface of the channel. 12. The device of claim 10 , wherein the channel is a fluidic channel etched on a transparent medium. 13. The device of claim 10 , wherein the channel is a tubular structure made of a transparent medium. 14. The device of claim 13 , wherein the whole blood surrounds the optical fiber as it flows through the channel. 15. The device of claim 10 , wherein the light is directed at the plasma layer at an angle sufficient to cause a reflection off of the plasma layer. 16. The device of claim 10 , wherein the measuring unit is a spectrophotometer.

Assignees

Inventors

Classifications

  • Tubular type; cavity type; multireflective · CPC title

  • Capillary cells; Microcells · CPC title

  • G01N33/49Primary

    Blood {(chemical methods for determining blood cell populations G01N33/5094; chemical analysis of blood groups or blood types G01N33/80)} · CPC title

  • Attenuated total reflection · CPC title

  • G01N21/05Primary

    Flow-through cuvettes (G01N21/09 takes precedence; handling fluid samples G01N1/10) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11480558B2 cover?
A method and a device for determining the concentration of an analyte in whole blood is disclosed. In one embodiment, the method includes generating a plasma layer in the whole blood sample. Furthermore, the method includes exposing the plasma layer to light. The method also includes capturing light reflected from the plasma layer. Additionally, the method includes analyzing the reflected light…
Who is the assignee on this patent?
Siemens Healthcare Diagnostics Inc
What technology area does this patent fall under?
Primary CPC classification G01N33/49. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Oct 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).